aid: abelzeta-pharma accessModel: pricing: unknown onboarding: unknown trial: false try_now: false public: false label: Unknown confidence: low source: [] generated: '2026-07-22' method: derived image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/abelzeta-pharma.png name: AbelZeta Pharma description: 'AbelZeta Pharma is a global clinical-stage cell therapy company discovering, developing, and manufacturing T-cell-based immunotherapeutics for cancer and immunological diseases. Its pipeline centers on Chimeric Antigen Receptor (CAR)-T cell technology across hematologic malignancies, solid tumors, and inflammatory and immunological conditions. Backed by Hongshan (formerly Sequoia Capital China), AbelZeta develops personalized immune cell therapies that empower patients'' own immune systems to address unmet medical needs, with operations in the United States (Maryland) and China. AbelZeta does not currently publish a public developer API; this profile captures the company''s corporate web presence and identity within the API Evangelist network.' url: https://raw.githubusercontent.com/api-evangelist/abelzeta-pharma/refs/heads/main/apis.yml x-type: company x-source: vc-portfolio x-backed-by: - hongshan x-tier: stub x-tier-reason: portfolio-lead specificationVersion: '0.20' created: '2026-07-17' modified: '2026-07-17' tags: - Company - Healthcare - Biotechnology - Cell Therapy - Immunotherapy - CAR-T - Pharmaceuticals - Oncology apis: [] common: - type: DomainSecurity url: security/abelzeta-pharma-domain-security.yml - type: Website url: https://www.abelzeta.com/ - type: Blog url: https://www.abelzeta.com/newsroom/ - type: Support url: https://www.abelzeta.com/contact/ - type: PrivacyPolicy url: https://www.abelzeta.com/privacy-policy/ - type: TermsOfService url: https://www.abelzeta.com/terms-and-conditions/ maintainers: - FN: Kin Lane email: kin@apievangelist.com - FN: APIs.json email: info@apis.io x-enrichment: date: '2026-07-19' status: backfilled pass: local-v1 note: backfilled from .gitignore signal + verified work evidence